FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979751018> ?p ?o ?g. }

• W2979751018 abstract "Abstract Abstract 1630 Sickle cell disease (SCD) is considered as a hypercoagulable state through still a mechanism poorly understood. Our hypothesis is that poor platelet plasma (PPP) from SCD children may contain a high phospholipids procoagulant activity. This study aimed 1° at using and comparing two different assays to detect the procoagulant activity of endogenous phospholipids (ePL) in the PPP of SCD children in steady state compared to normal controls, 2° at assessing the influence of the clinical state and treatment on this procoagulant activity. Patients: A group of 30 SCD children aged between 2 – 20 years (median=9, 16 males, 14 females) were studied: 12/30 didn't receive any specific treatment, 6/30 were chronically transfused (TRX) and 12/30 were treated by hydroxyurea (HU). 11/30 were previously admitted because of a vaso-occlusive crisis (VOC). 24 SCD patients were HbSS, 4 HbSC, and 2 HbSβ. Controls: 18 remaining samples from children aged between 3 – 20 years (median=9, 11 males, 7 females) undergoing minor elective surgery, with no history of coagulation disorder, normal routine coagulation tests, normal CRP, liver and kidney functions tests. The controls were not matched for the age neither sex. Venous blood was collected into 0,109M citrated tubes using a 23G butterfly needle. PPP was obtained after 2 steps of centrifugation (3200g for 15 min and 16000g for 2 min) within 2 hours following venipuncture, and stored at -80°C. Procoagulant activity of ePL was assessed using two independent assays: a commercial fully automated factor Xa-based clotting time assay (XACT: sec) as described by Exner et al (ProcoagPPL® Stago, Asnières sur Seine, France), and a thrombin generation assay (TGA) using calibrated automated thrombinography (CAT) as described by Hemker et al (Thrombinoscope®, Maastricht, The Netherland). TGA was triggered with 10pM tissue factor (TF) alone and with a combination of 10pM TF and 4μM synthetic PL (positive control). Four TGA parameters were analysed: lag time (LT), Peak, Velocity Index (VI) and Endogenous Thrombin Potential (ETP). For each parameter, the result was also expressed as a % of the positive control, to minimize the influence of age. Correlations were assessed between XACT and TGA parameters using the Spearman's coefficient. Group comparison was assessed using non parametric tests. Significant correlations were found between XACT and Peak (r= -0,76, p<0,0001), VI (r= -0,73, p<0,0001), ETP (r= -0,47, p<0,0001) measured without addition of PL, and also between XACT and % Peak (r= -0,73, p<0,0001), %VI (r= -0,63, p<0,0001) and % ETP (r= -0,60, p<0,0001). No correlation was found between XACT and LT (r= 0,20, p = 0,096). The table shows median and range values obtained from SCD patients in steady state as compared to those of normal controls, using both methods. The TGA values are those obtained with 10pM alone, and are also expressed as a percentage of positive control. Concerning the clinical state and treatment, XACT and all CAT parameters failed to show significant differences between subgroups of SCD (steady vs. CVO, n=11), and their treatment (TRX vs. HU vs. No specific treatment). For the patients undergoing chronic exchange transfusion, no significant difference was observed between the samples collected before and few hours after transfusion exchange. In SCD children in steady state, XACT is significantly shortened compared to normal controls. Velocity index and Peak thrombin are significantly increased when using a high TF concentration alone as trigger. Each test showed similar performance to detect a higher procoagulant activity of ePL in SCD patients, which could contribute to the hypercoagulable state observed in those patients. In our study, ePL procoagulant activity was not influenced by the clinical state, neither the type of treatment, but this could be due to the relatively small number of patients included till now. We are currently studying more patients to confirm our results in a larger group and in particular to analyze the effects of treatment. Disclosures: Noubouossie: Belgian Kid's Fund: Grant's recipient of the Belgian Kid's Funds." @default.
• W2979751018 created "2019-10-18" @default.
• W2979751018 creator A5006080143 @default.
• W2979751018 creator A5019188950 @default.
• W2979751018 creator A5044154938 @default.
• W2979751018 creator A5053902929 @default.
• W2979751018 creator A5088642491 @default.
• W2979751018 date "2010-11-19" @default.
• W2979751018 modified "2023-09-29" @default.
• W2979751018 title "Two Independant Assays Demonstrate High Phospholipid Procoagulant Activity In Poor Platelet Plasma of Sickle Cell Disease Children." @default.
• W2979751018 doi "https://doi.org/10.1182/blood.v116.21.1630.1630" @default.
• W2979751018 hasPublicationYear "2010" @default.
• W2979751018 type Work @default.
• W2979751018 sameAs 2979751018 @default.
• W2979751018 citedByCount "0" @default.
• W2979751018 crossrefType "journal-article" @default.
• W2979751018 hasAuthorship W2979751018A5006080143 @default.
• W2979751018 hasAuthorship W2979751018A5019188950 @default.
• W2979751018 hasAuthorship W2979751018A5044154938 @default.
• W2979751018 hasAuthorship W2979751018A5053902929 @default.
• W2979751018 hasAuthorship W2979751018A5088642491 @default.
• W2979751018 hasConcept C126322002 @default.
• W2979751018 hasConcept C141071460 @default.
• W2979751018 hasConcept C203014093 @default.
• W2979751018 hasConcept C2778382381 @default.
• W2979751018 hasConcept C2778620579 @default.
• W2979751018 hasConcept C2779134260 @default.
• W2979751018 hasConcept C2780976302 @default.
• W2979751018 hasConcept C43044207 @default.
• W2979751018 hasConcept C71924100 @default.
• W2979751018 hasConcept C74414138 @default.
• W2979751018 hasConcept C77171857 @default.
• W2979751018 hasConcept C89560881 @default.
• W2979751018 hasConcept C90924648 @default.
• W2979751018 hasConceptScore W2979751018C126322002 @default.
• W2979751018 hasConceptScore W2979751018C141071460 @default.
• W2979751018 hasConceptScore W2979751018C203014093 @default.
• W2979751018 hasConceptScore W2979751018C2778382381 @default.
• W2979751018 hasConceptScore W2979751018C2778620579 @default.
• W2979751018 hasConceptScore W2979751018C2779134260 @default.
• W2979751018 hasConceptScore W2979751018C2780976302 @default.
• W2979751018 hasConceptScore W2979751018C43044207 @default.
• W2979751018 hasConceptScore W2979751018C71924100 @default.
• W2979751018 hasConceptScore W2979751018C74414138 @default.
• W2979751018 hasConceptScore W2979751018C77171857 @default.
• W2979751018 hasConceptScore W2979751018C89560881 @default.
• W2979751018 hasConceptScore W2979751018C90924648 @default.
• W2979751018 hasLocation W29797510181 @default.
• W2979751018 hasOpenAccess W2979751018 @default.
• W2979751018 hasPrimaryLocation W29797510181 @default.
• W2979751018 hasRelatedWork W1896118434 @default.
• W2979751018 hasRelatedWork W2012146314 @default.
• W2979751018 hasRelatedWork W2037929462 @default.
• W2979751018 hasRelatedWork W2346224373 @default.
• W2979751018 hasRelatedWork W2393714909 @default.
• W2979751018 hasRelatedWork W2522073881 @default.
• W2979751018 hasRelatedWork W2526174228 @default.
• W2979751018 hasRelatedWork W2536228301 @default.
• W2979751018 hasRelatedWork W2562751034 @default.
• W2979751018 hasRelatedWork W2565461029 @default.
• W2979751018 hasRelatedWork W2567122896 @default.
• W2979751018 hasRelatedWork W2585563407 @default.
• W2979751018 hasRelatedWork W2588265766 @default.
• W2979751018 hasRelatedWork W2588346653 @default.
• W2979751018 hasRelatedWork W2588818752 @default.
• W2979751018 hasRelatedWork W2734807454 @default.
• W2979751018 hasRelatedWork W2955424641 @default.
• W2979751018 hasRelatedWork W2978736210 @default.
• W2979751018 hasRelatedWork W2992861880 @default.
• W2979751018 hasRelatedWork W964180175 @default.
• W2979751018 isParatext "false" @default.
• W2979751018 isRetracted "false" @default.
• W2979751018 magId "2979751018" @default.
• W2979751018 workType "article" @default.